Our approach to osteoporosis screening and treatment needs to change.
Cooper
Mark S
MS
Department of Endocrinology, Division of Medical Sciences, University of Birmingham and Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom. M.S.Cooper@bham.ac.uk
D015502:Absorptiometry, Photon; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D006301:Health Services Needs and Demand / Q000592:standards* / Q000639:trends; D006801:Humans; D008403:Mass Screening / Q000592:standards*; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D015995:Prevalence
D050071:Bone Density Conservation Agents